A retrospective review of family studies in reclassifying variants of unknown significance detected in cardiomyopathy multigene panels

Date:
Wednesday, Sep 28, 2016 11:00am – 12:00pm
Conference:
NSGC 2016
Authors:
Alizabeth Berg, Andrea Nagl, Brigette Tippin Davis, Heather Workman, Ira Lu, Jill Dolinsky, Kendra Walller, Melissa Dempsey, Sara Calicchia, Tami Johnston

Multigene panel tests (MGPT) for cardiomyopathy (CM) have been available for clinical diagnostic testing at Ambry Genetics since 2012, with panels ranging from 2-85 genes.